These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8856144)

  • 1. A new class of potent bradykinin antagonist dimers.
    Gera L; Stewart JM; Whalley E; Burkard M; Zuzack JS
    Immunopharmacology; 1996 Jun; 33(1-3):178-82. PubMed ID: 8856144
    [No Abstract]   [Full Text] [Related]  

  • 2. A new class of bradykinin antagonists containing indanylglycine.
    Gera L; Stewart JM
    Immunopharmacology; 1996 Jun; 33(1-3):174-7. PubMed ID: 8856143
    [No Abstract]   [Full Text] [Related]  

  • 3. New bradykinin antagonists having very high potency at B1 receptors.
    Gera L; Stewart JM; Whalley ET; Burkard M; Zuzack JS
    Immunopharmacology; 1996 Jun; 33(1-3):183-5. PubMed ID: 8856145
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors.
    Burkard M; Zuzack JS; Jones S; Francis M; Whalley ET; Stewart JM; Gera L
    Immunopharmacology; 1996 Jun; 33(1-3):186-90. PubMed ID: 8856146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and highly potent bradykinin antagonists.
    Knolle J; Breipohl G; Henke S; Wirth K; Schölkens B
    Agents Actions Suppl; 1992; 38 ( Pt 1)():559-64. PubMed ID: 1334632
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors.
    Hanson WL; McCullough RG; Selig WM; Wieczorek M; Ross S; Whalley ET; Stewart JM; Gera L
    Immunopharmacology; 1996 Jun; 33(1-3):191-3. PubMed ID: 8856147
    [No Abstract]   [Full Text] [Related]  

  • 7. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new generation of bradykinin antagonists.
    Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
    Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides.
    Kyle DJ; Martin JA; Burch RM; Carter JP; Lu SF; Meeker S; Prosser JC; Sullivan JP; Togo J; Noronha-Blob L
    J Med Chem; 1991 Aug; 34(8):2649-53. PubMed ID: 1652027
    [No Abstract]   [Full Text] [Related]  

  • 10. Inducible bradykinin B1 receptor in isolated human ileum.
    Zuzack JS; Burkard MR; Cuadrado DK; Greer RA; Selig WM; Whalley ET
    Immunopharmacology; 1996 Jun; 33(1-3):113-5. PubMed ID: 8856127
    [No Abstract]   [Full Text] [Related]  

  • 11. Hybrid peptides having mixed substance P (NK1), neurokinin A (NK2) and bradykinin (BK2) antagonist properties.
    Srivastava VP; Goodfellow VS; Zuzack JS; Jones S; Francis M; Beckey VE; Whalley ET
    Immunopharmacology; 1996 Jun; 33(1-3):194-7. PubMed ID: 8856148
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-selectivity of new bradykinin antagonists for B1 receptors.
    Rhaleb NE; Gobeil F; Regoli D
    Life Sci; 1992; 51(11):PL125-9. PubMed ID: 1326066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudopeptide analogs of bradykinin and bradykinin antagonists.
    Vavrek RJ; Gera L; Stewart JM
    Agents Actions Suppl; 1992; 38 ( Pt 1)():565-71. PubMed ID: 1466297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel bradykinin antagonist dimers for the treatment of human lung cancers.
    Chan D; Gera L; Helfrich B; Helm K; Stewart J; Whalley E; Bunn P
    Immunopharmacology; 1996 Jun; 33(1-3):201-4. PubMed ID: 8856150
    [No Abstract]   [Full Text] [Related]  

  • 15. Potent, long-acting bradykinin antagonists for a wide range of applications.
    Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
    Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [125I]PIP HOE 140, a high affinity radioligand for bradykinin B2 receptors.
    Brenner NJ; Stonesifer GY; Schneck KA; Burns HD; Ransom RW
    Life Sci; 1993; 53(25):1879-86. PubMed ID: 8255148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and conformational analysis of several highly potent bradykinin receptor antagonists.
    Kyle DJ; Martin JA; Farmer SG; Burch RM
    J Med Chem; 1991 Mar; 34(3):1230-3. PubMed ID: 1848297
    [No Abstract]   [Full Text] [Related]  

  • 18. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
    Meini S; Lecci A; Maggi CA
    Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin).
    Rhaleb NE; Rouissi N; Jukic D; Regoli D; Henke S; Breipohl G; Knolle J
    Eur J Pharmacol; 1992 Jan; 210(2):115-20. PubMed ID: 1601053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of a bradykinin B1/B2 antagonist linked to a human neutrophil elastase inhibitor; a heterodimer for the treatment of inflammatory disorders.
    Leimer AH; Kroona HB; Blodgett JK; Whalley ET; Ross SE; Burkard MR; Zuzack JS; Gernert DL; Dyckes DF
    Can J Physiol Pharmacol; 1997 Jun; 75(6):633-8. PubMed ID: 9276141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.